pluri’s
MEDIA & EVENTS

BLOG

Pluri: Where Technology Comes to Life

On July 25, 2022

Cells are the very fabric of our universe: Everything in this world begins and ends with cells. Technology that harnesses the innate power of cells, and their ability to expand rapidly, therefore has the potential to change the world. We…

How can Pluri’s technology help the environment?

On June 5, 2022

We only have one earth. This is why we at Pluri are committed to creating a better planet on World Environment Day and every day. These campaigns are important to shine a spotlight on our global footprint. To ensure we…

Pluri’s Cell-Based Technology Platform, Promoting a Better Future

On May 16, 2022

Key global challenges in sustainable development Humans are the most populous large animal on earth today. In fact, the average global human population grows by 2.6 people every second (81 million people per year). That’s a lot of people and…

Pluri’s Innovative Therapy Could Treat Acute Radiation Syndrome in a Nuclear Event

On March 31, 2022

Encouraging results from Pluri’s recent Phase 1 clinical trial not only give patients with bone marrow failure hope for a better recovery, but also reinforce the innovative cell therapy product candidate PLX-R18 as a potential treatment for radiation exposure….

Positive Topline Phase I Results – Hematology Program

On June 29, 2021

In a press release dated April 29, 2021, we reported positive topline Phase I results in our innovative hematology program. This study, the first to evaluate PLX-R18 in humans, demonstrated that PLX-R18 had the potential to stimulate the bone marrow…

©2023 Pluri Inc.

©2023 Pluri Inc., its logo, brand, product, and process names appearing in this issue are the trademarks of Pluri™ Inc. or its affiliated companies. All other brand, product, and process names appearing are the trademarks of their respective holders. Reference to or use of a product, or process other than those of Pluri™ Inc. does not imply recommendation, approval, affiliation, or sponsorship of that product, or process by Pluri™ Inc. Nothing contained herein shall be construed as conferring by implication, estoppel, or otherwise any license or right under any patent, copyright, trademark, or other intellectual property right of Pluri™ Inc. or any third party, except as expressly granted herein.  All information herein is for general information only and is subject for change without notice.

NAME

Title

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.